Pharmacology, Toxicology and Pharmaceutical Science
Adult Respiratory Distress Syndrome
33%
Coronavirinae
100%
Cytokine Storm
100%
Diseases
100%
Hyperferritinemia
16%
Interleukin 6
50%
Monoclonal Antibody
16%
Multiple Organ Failure
33%
Randomized Controlled Trial
16%
Receptor
33%
SARS Coronavirus
16%
Syndrome
100%
Tocilizumab
100%
Keyphrases
Acute Respiratory Distress Syndrome
33%
Adverse Effects
16%
Clinical Characteristics
16%
Clinical Manifestations
16%
Close Monitoring
16%
COVID-19
100%
Cytokine Storm Syndrome
100%
Hyperferritinemia
16%
IL-6 Level
16%
IL-6 Receptor
33%
Male Patients
16%
Monoclonal Antibody
16%
Multiple Organ Failure
33%
Number of Subjects
16%
Randomized Controlled Trial
16%
Severe Cases
33%
Tocilizumab
100%
Transmission Rate
16%
Young Males
16%
Medicine and Dentistry
Acute Respiratory Distress Syndrome
33%
Adverse Effect
16%
Coronavirinae
100%
Cytokine Storm
100%
Diseases
100%
Hyperferritinemia
16%
Interleukin 6
50%
Monoclonal Antibody
16%
Multiple Organ Dysfunction Syndrome
33%
Randomized Controlled Trial
16%
Receptor
33%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Tocilizumab
100%